Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - TANDEM DIABETES CARE INC | tndm-20191231xex322.htm |
EX-32.1 - EXHIBIT 32.1 - TANDEM DIABETES CARE INC | tndm-20191231xex321.htm |
EX-31.2 - EXHIBIT 31.2 - TANDEM DIABETES CARE INC | tndm-20191231xex312.htm |
EX-31.1 - EXHIBIT 31.1 - TANDEM DIABETES CARE INC | tndm-20191231xex311.htm |
EX-10.36 - EXHIBIT 10.36 LEASE AGREEMENT - TANDEM DIABETES CARE INC | tndm-20191231xex1036.htm |
EX-4.1 - EXHIBIT 4.1 DESCRIPTION OF CAPITAL STOCK - TANDEM DIABETES CARE INC | tndm-20191231xex47.htm |
10-K - 10-K - TANDEM DIABETES CARE INC | tndm-20191231x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-222143) of Tandem Diabetes Care, Inc.,
(2) Registration Statement (Form S-8 No. 333-226944) pertaining to the 2013 Stock Incentive Plan of Tandem Diabetes Care Inc.,
(3) Registration Statement (Form S-8 No. 333-226915) pertaining to the 2013 Stock Incentive Plan, and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc.,
(4) Registration Statement (Form S-8 No. 333-192406) pertaining to the 2006 Stock Incentive Plan, 2013 Stock Incentive Plan, and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc.,
(5) Registration Statement (Form S-8 No. 333-202254) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care, Inc.,
(6) Registration Statement (Form S-8 No. 333-209685) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care, Inc.,
(7) Registration Statement (Form S-8 No. 333-223377) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc., and
(8) Registration Statement (Form S-8 No. 333-216529) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc;
of our reports dated February 24, 2020, with respect to the consolidated financial statements of Tandem Diabetes Care, Inc. and the effectiveness of internal control over financial reporting of Tandem Diabetes Care, Inc., included in this Annual Report (Form 10-K) of Tandem Diabetes Care, Inc. for the year ended December 31, 2019.
/s/Ernst & Young LLP
San Diego, California
February 24, 2020